Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)

Venerito, M.Rimassa, L.Cicin, IBlanc, J-FKluempen, H-JZagonel, VTran, A.2024-06-122024-06-1220182296-52702296-5262https://hdl.handle.net/20.500.14551/26808[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)Conference Object41283283Q4WOS:000446816500688